PNV
POLYNOVO FPO [PNV]
Healthcare · ASX Small Cap
$0.9270 -3.9%
Updated 2026-03-02 · Scores refresh every scan
Appeared in 2 consecutive scans→ Score +6First seen: 2026-02-25
Score Breakdown
Technical49
Catalyst51
Sentiment50
Fundamental89
Momentum58
Risk Gate40
Active Signals
Bullish Signals
- RSI approaching oversold
- Bollinger squeeze (breakout building)
- Cash positive / operating cashflow positive
- Low P/S ratio (4.6x)
- Moderate revenue growth (+18%)
- Piotroski F-Score strong (8/9)
- EPS estimates revised upward (+10pts)
- Near 52-week low (7% of range)
- Very high short interest (12.8%)
- Earnings in sharp decline (-100% QoQ)
- CANSLIM A: Turned profitable
- CANSLIM I: Institutional ownership (31%)
- Earnings momentum: 2 consecutive improvements
- Analyst EPS expectations rising (+205%)
- Days to cover very high (29.8)
- ASX200 bullish (+1.5% 5d)
- RBA cutting (+2pts)
- Trial readout: NA (est. 2018-09-06)
Risk Signals
- Price below MAs (downtrend)
- Below 200-day MA (long-term downtrend)
- Post-earnings drift: negative surprise (SUE -10)
- Insufficient sentiment data (defaulting to neutral)
- Neutral/mixed sentiment
Recent Catalysts
NONE Change of Director's Interest Notice - Andrew Lumsden
NONE Change of Director's Interest Notice
NONE Webcast Recording - 1H26 Financial Results
Recent ASX Announcements
| 2026-02-27 | Change of Director's Interest Notice - Andrew Lumsden |
| 2026-02-27 | Change of Director's Interest Notice |
| 2026-02-24 | Webcast Recording - 1H26 Financial Results |
| 2026-02-20 | 1H FY26 Results Presentation PRICE SENSITIVE |
| 2026-02-20 | Appendix 4D & H1 FY26 Financial Statements PRICE SENSITIVE |
Key Metrics
$640.4M
Market Cap
3.0M
Avg Volume
0.9x
Vol Ratio
$0.87 — $1.72
52-Week Range
12.8%
Short Interest
N/A
Cash Runway
12.5%
ROE
7.1%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: -100% |
| A | Annual Earnings | improving | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 87% |
| L | Leader vs Laggard | laggard | RS: -5 |
| I | Institutional Sponsorship | pass | Inst: 31% |
| M | Market Direction | pass | Bullish |
Sector: Healthcare
Ranked #8 of 119 · Sector avg: 51
View all Healthcare signals →